Molecular Epidemiology of Hypertrophic Cardiomyopathy
Authors:
- S.R. DepalmaSDS.R. Depalma
- M. AradMAM. Arad
- B. McdonoughBMB. Mcdonough
- S. BarrSBS. Barr
- C. DuffyCDC. Duffy
- B.J. MaronBMB.J. Maron
- C.E. SeidmanCSC.E. Seidman
- J.G. SeidmanJSJ.G. Seidman
- 1 January 2002
- journal article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Symposia on Quantitative Biology
- Vol. 67, 383-388
Abstract
Detailed reviews describing work presented at the annual Cold Spring Harbor Symposia on Quantitative BiologyKeywords
This publication has 21 references indexed in Scilit:
- Mutations of the Light Meromyosin Domain of the β-Myosin Heavy Chain Rod in Hypertrophic CardiomyopathyCirculation Research, 2002
- Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathyNature Genetics, 2002
- Inherited and de novo Mutations in the Cardiac Actin Gene Cause Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 2000
- Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathyNature Genetics, 1997
- THE MAMMALIAN MYOSIN HEAVY CHAIN GENE FAMILYAnnual Review of Cell and Developmental Biology, 1996
- Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscleNature Genetics, 1996
- Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathyNature Genetics, 1995
- α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomereCell, 1994
- A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3Nature Genetics, 1993
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationCell, 1990